Kindred Biosciences, Inc. Email Format
BiotechnologyCalifornia, United States51-200 Employees
Kindred Biosciences, Inc. is a development-stage biotechnology company focused on creating therapeutics for pets, primarily dogs, cats, and horses, with the aim of translating human-validated targets and compounds into veterinary medicines. The company emphasizes advancing safety and efficacy by leveraging established human research foundations, pursuing programs across small molecules and biologics, and has submitted major technical sections of an FDA New Animal Drug Application for two product candidates. Based in the San Francisco Bay Area in California, the firm operates with a mid-sized life sciences team and concentrates on addressing unmet medical needs in the pet therapeutics market. KindredBio positions itself within the animal health biotech sector, seeking faster development timelines and higher approval potential by using validated targets. Its strategy includes building a pipeline of product candidates and maintaining collaborations while exploring long-acting formulations and novel technologies for pet medications. In recent activity, the company has engaged in partnerships and organizational initiatives, reflecting ongoing efforts to expand its development programs and presence in the market for veterinary therapeutics.